ACNR posted: IQoro for stroke-related dysphagia
The UK based, international, peer reviewed journal, Advances in Clinical Neuroscience and Rehabilitation (ACNR), posted in the section of Industry News on 1ST of August:
“NICE has developed a Medtech Innovation Briefing (MIB) with advice to aid local decision making on the use of IQoro for stroke-related dysphagia. Concluding their in-depth study of the effectiveness of IQoro® in the treatment of the legacy of stroke, NICE judged it to be unique, innovative and that the intended place in therapy would be as well as standard speech and language therapy in people with stroke-related dysphagia.” (Volume 18, Issue 4 May – July 2019)
Advances in Clinical Neuroscience and Rehabilitation (ACNR) is a UK-based, international, peer reviewed journal which aims to keep busy practicing specialists up-to-date with the latest advances in their fields, including areas of neurology and neuroscience outside their main area of sub-specialty interest.
Read more: Medtech innovation briefing [MIB175]